Kentucky Cannabis Program Sees Regulatory Clarification, Expanding List Of Treatable Conditions

Kentucky’s cannabis space is witnessing a steady incremental expansion as Gov. Andy Beshear signed on Tuesday an executive order that further clarified eligibility for medical cannabis while updating the list of qualifying medical conditions.

The move is an answer to prior calls for clarification from the Office of Medical Cannabis, the Team Kentucky Medical Cannabis Workgroup, and the Board of Physicians and Advisors.

The list of qualifying conditions now includes terminal illness, sickle cell anemia, ALS, Parkinson’s disease, HIV/AIDS, Huntington’s disease, muscular dystrophy, cachexia (wasting syndrome), Crohn’s disease, ulcerative colitis, neuropathies, severe arthritis, fibromyalgia, and glaucoma.

The policy change addressed a lack of clarity in the state’s existing medical cannabis program around who is eligible to access medical cannabis legally, rather than expanding it. The issue arose around certain conditions, such as chronic pain and muscle spasms, which are symptoms of underlying serious diseases.

“The law is meant to provide a safe alternative form of pain relief for Kentuckians suffering, yet the law’s lack of clarity prevented too many people from receiving help. This step makes the law clearer,” Gov. Beshear said in a press release. “With the progress we’ve made to reduce overdose deaths and fight addiction, it’s important we continue to offer an alternative to dangerous and addictive opioids.

In Kentucky, medical cannabis has been legal since Jan 1, 2025, under Senate Bill 47, which Gov. Beshear signed into law in 2023. The Kentucky Office of Medical Cannabis has been accepting applications from businesses since July 1, 2024.